Vasculitis

Large Vessel Vasculitis Outcome Measures: An Update from OMERACT

March 19, 2019 • By Carina Stanton

Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality

February 14, 2019 • By Carina Stanton

DADA2: A New Disease for Rheumatologists to Understand

January 17, 2019 • By Jason Liebowitz, MD

Case Report: Lymphocytic Vasculitis of the Central Nervous System

January 17, 2019 • By Gbemisola Olayemi, MD, Evangeline Scopelitis, MD, & Jerald M. Zakem, MD

Zoster Reactivation Risk in Patients Treated with Cyclophosphamide

December 18, 2018 • By Susan Bernstein

Case Report: A Behçet’s Patient Develops Cerebral Venous Sinus Thrombi

December 17, 2018 • By Javaneh Lyons, MD, MSc, Alana Nevares, MD

AAV Remission Study: Does Rituximab or Azathioprine Work Best?

December 17, 2018 • By Thomas R. Collins

Rituximab Maintenance Study: Is Fixed-Schedule or Tailored Dosing Best?

December 17, 2018 • By Kurt Ullman

Course of treatment over time

Case Report: The Hairdresser Who Couldn’t Comb Hair

November 19, 2018 • By Erin Hammett, DO, & Edward Skol, MD

Trimethoprim-Sulfamethoxazole Prophylaxis Reduced Rituximab Infection Risk

October 18, 2018 • By Kathy Holliman